Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Topical finasteride is an effective and safer treatment for male hair loss.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

5% minoxidil foam effectively treats female hair loss.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Dutasteride is a safe and effective treatment for hair loss.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

DHEA treatment helps grow pubic hair and boosts mood in girls with adrenal issues.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

The botanical treatment for hair loss shows promise, especially for children.

Sublingual minoxidil safely promotes hair growth.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.